CHICAGO – The two-year trail that follows Huascar Brazobán through the 2024 trade deadline and into this one tells you something about what relief pitchers who actually work at this level look like. He posted a 2.56 ERA for the Marlins in 2024 before Miami moved him to the Mets at the deadline. Two summers later, his ERA is still 2.56 with New York. The White Sox, rebuilding with intent rather than patience, decided that track record was worth a pair of prospects.
Chicago acquired the 36-year-old right-hander from the Mets on Sunday in exchange for Double-A pitcher Gabe Davis and Triple-A reliever Zach Franklin, according to MLB.com. Brazobán enters his fifth major league season in his third organization, a well-traveled résumé for a pitcher who has not given the teams above him a reason to keep moving him.
The numbers that moved him to Chicago are not a fluke. In 2024 with Miami, Brazobán appeared in 46 games and threw 52 2/3 innings, with 49 strikeouts and 23 walks, an ERA that sat below most of the league’s reliable relievers. His 2026 season with the Mets produced the same arithmetic: a 2.56 ERA and a 5-2 record that signals sustained productivity, not a hot stretch. The White Sox had a specific need and found a reliever who, for two consecutive seasons with two different organizations, has been the answer to exactly that question.
The acquisition fits a pattern taking shape at Guaranteed Rate Field this week. Three days before the Brazobán deal, Chicago completed the acquisition of Luis Castillo from the Seattle Mariners, adding a three-time All-Star to a rotation that had been the club’s most visible deficiency. That move addressed the front end of a pitching staff. This one addresses the back.
What Chicago gave up reflects where both teams are in their organizational cycle. Davis, ranked 18th in the White Sox system, carries a 5.81 ERA across 18 minor-league starts this season, a 2025 fifth-round pick with upside the Mets were willing to project on. Franklin, currently at Triple-A Charlotte, holds a 4.37 ERA with five saves in 33 appearances. Neither is a core prospect in Chicago’s rebuild. Both give the Mets something to develop while their roster reconfigures.
For New York, this is a calculated step back. Not distress selling, but an acknowledgment that the deadline offered a window to move an asset while the return was still meaningful. Brazobán’s contract status and the team’s trajectory through the second half left the Mets with limited arguments for holding him. Davis and Franklin give them organizational depth with arms to develop.
Brazobán turns 37 in September. That context matters. This is not a multi-year bet on a pitcher entering a peak. It is a targeted acquisition from a team that has decided the most useful thing a 36-year-old with a 2.56 ERA can do is pitch in Chicago from now until October. Whether the division standings agree with that framing is August’s business. The White Sox appear to have decided the argument is worth making.
Where he slots in the bullpen depends on what the coaching staff sees when he arrives. The White Sox have rotated through their late-inning options without settling on a consistent answer for high-leverage situations, the kind of question a pitcher with Brazobán’s sustained numbers is designed to answer. His role will likely be earned rather than assigned, but his ERA over two consecutive seasons suggests the competition for that role has already identified a favorite.
This deadline, the White Sox have been the buyers. That is not the framing the franchise has occupied in recent memory. Adding Castillo and Brazobán in the same week, two established major-league pitchers for the rotation and the bullpen, signals that the organization believes the gap between where it is and where it needs to be has narrowed enough to accelerate. Whether that assessment proves correct is what the standings will verify.
What Brazobán himself cannot guarantee is that the 2024 and 2026 versions of himself show up in Chicago in the same form. He has posted the same ERA in two different organizations over two seasons. That consistency is evidence, not a contract. The White Sox are betting the evidence is reliable. Baseball tends to produce its own answer to that kind of wager, usually by September.
The organization’s deadline week is over. Davis and Franklin are in New York. Brazobán is in Chicago. Two prospects for a proven reliever, the simplest trade logic available, executed exactly when the White Sox decided they were no longer content to wait.
